Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new revision label, updating from v3.5.2 to v3.5.3. This indicates a minor editorial or system-level update rather than a change to the study information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study details or page content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; this is a metadata change and does not alter the study details.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 was added and the v3.4.1 notice was removed. This appears to be a site maintenance update that does not affect the clinical trial details on the page.SummaryDifference0.5%

- Check91 days agoChange DetectedSite-wide notices were added about government funding lapse and clinic operations, and the site revision was updated to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.